company background image
AKUM.Q logo

Akumin OTCPK:AKUM.Q Stock Report

Last Price

US$0.38

Market Cap

US$34.2m

7D

-12.8%

1Y

-67.7%

Updated

07 Feb, 2024

Data

Company Financials

AKUM.Q Stock Overview

Akumin Inc. provides outpatient diagnostic imaging services in the United States. More details

AKUM.Q fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Akumin Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Akumin
Historical stock prices
Current Share PriceUS$0.38
52 Week HighUS$1.30
52 Week LowUS$0.12
Beta0.15
1 Month Change9.16%
3 Month Change14.02%
1 Year Change-67.67%
3 Year Change-88.39%
5 Year Change-89.92%
Change since IPO-90.42%

Recent News & Updates

Recent updates

These 4 Measures Indicate That Akumin (NASDAQ:AKU) Is Using Debt Extensively

Aug 26
These 4 Measures Indicate That Akumin (NASDAQ:AKU) Is Using Debt Extensively

Akumin CFO William Larkin terminated, David Kretschmer named interim CFO

Aug 15

Shareholder Returns

AKUM.QUS HealthcareUS Market
7D-12.8%-4.1%-2.4%
1Y-67.7%-10.2%23.4%

Return vs Industry: AKUM.Q underperformed the US Healthcare industry which returned 0.3% over the past year.

Return vs Market: AKUM.Q underperformed the US Market which returned 15.8% over the past year.

Price Volatility

Is AKUM.Q's price volatile compared to industry and market?
AKUM.Q volatility
AKUM.Q Average Weekly Movement9.5%
Healthcare Industry Average Movement7.6%
Market Average Movement6.3%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: AKUM.Q has not had significant price volatility in the past 3 months.

Volatility Over Time: AKUM.Q's weekly volatility has decreased from 25% to 10% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2015n/aRiadh Zine Zine-El-Abidinewww.akumin.com

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations.

Akumin Inc. Fundamentals Summary

How do Akumin's earnings and revenue compare to its market cap?
AKUM.Q fundamental statistics
Market capUS$34.19m
Earnings (TTM)-US$255.79m
Revenue (TTM)US$737.69m

0.0x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AKUM.Q income statement (TTM)
RevenueUS$737.69m
Cost of RevenueUS$569.72m
Gross ProfitUS$167.97m
Other ExpensesUS$423.77m
Earnings-US$255.79m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.81
Gross Margin22.77%
Net Profit Margin-34.68%
Debt/Equity Ratio-1,459.1%

How did AKUM.Q perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/07 16:54
End of Day Share Price 2024/02/06 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Akumin Inc. is covered by 5 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tania Armstrong-WhitworthCanaccord Genuity
Noel AtkinsonClarus Securities Inc.
Kyle McPheeCormark Securities Inc.